Back to News
Market Impact: 0.3
Nvidia, QIA-backed Iambic Therapeutics files for US IPO as biotech boom rolls on
Source: reuters.com
IPOs & SPACsHealthcare & BiotechPrivate Markets & Venture
Iambic Therapeutics, a drug developer backed by Nvidia and Qatar's sovereign wealth fund, filed for a U.S. IPO on Monday. The filing adds to an active fall biotech-listing pipeline and signals continued investor appetite for venture-backed life-sciences issuers.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
NVDA0.10
More News
- Johnson & Johnson May Offload Its Orthopedics Unit for $20 Billion -- and Investors Shouldn't Miss What That Could Signal
- London neocloud Nscale takes its $1B loss to Wall Street
- Anthropic and OpenAI navigate AI regulation ahead of IPOs
- Why Turning Point Brands Stock Dived by 10% Today
- Why Novo Nordisk Stock Just Crashed
- The Case for (and Against) Buying SpaceX Stock Right Now